FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
F/M Emerald Life Sciences Innovation ETF ETF AnalysisComprehensive ETF analysis for F/M Emerald Life Sciences Innovation ETF (LFSC) including NAV, expense ratio, sector breakdown, and holdings data.ETF AnalysisLFSC
LFSC
F/M Emerald Life Sciences Innovation ETF
LFSC
  1. Home
  2. Screener
  3. F/M Emerald Life Sciences Innovation ETFLFSCETF
F/M Emerald Life Sciences Innovation ETF Logo

F/M Emerald Life Sciences Innovation ETF

ETF
🇺🇸LFSC•NASDAQ•Equity

Your view on LFSC

F/M Emerald Life Sciences Innovation ETF Logo

F/M Emerald Life Sciences Innovation ETF

ETFEmerald
🇺🇸LFSC•NASDAQ•Equity
AUM (USD)$127.00M
Expense Ratio0.79%
Holdings0

Sentiment

AUM (USD)

$127.00M

Expense Ratio

0.79%

Holdings

0

Sentiment

LFSC
F/M Emerald Life Sciences Innovation ETF
LFSC

Overview for F/M Emerald Life Sciences Innovation ETF

Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc
Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc
Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc

About this fund

LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to …

LFSC Stock Price

Key Facts

Equity

Expense Ratio

0.79%

AUM

$127.00M

Fund Details

NAV$45.28 USD
Average Volume4.1K
Inception DateOctober 30, 2024
Asset ClassEquity
Fund IssuerEmerald
DomicileUS
ISINUS74933W2219
CUSIP74933W221
NAV CurrencyUSD

Expense Ratio

0.79%

Assets Under Management

$127.00M

NAV

$45.28 USD

Average Volume

4.1K

Inception Date

October 30, 2024

Asset Class

Equity

Fund Issuer

Emerald

Domicile

US

ISIN

US74933W2219

CUSIP

74933W221

NAV Currency

USD

Expense Ratio

0.79%

Assets Under Management

$127.00M

NAV

$45.28 USD

Average Volume

4.1K

Inception Date

October 30, 2024

Asset Class

Equity

Fund Issuer

Emerald

Domicile

US

ISIN

US74933W2219

CUSIP

74933W221

NAV Currency

USD

Data last updated: Sep 14, 2026, 07:10 AM

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

News

Latest Market News

What is LFSC?

F/M Emerald Life Sciences Innovation ETF (LFSC) is a Equity fund from Emerald, listed since 2024, with $127.0M in assets under management, a 0.79% expense ratio, a NAV of $45.28 USD.

What's in LFSC? Top 10 holdings

HoldingWeight
Corcept Therapeutics Inc CORT7.49%
LivaNova PLC LIVN6.67%
Travere Therapeutics Inc TVTX6.56%
Cogent Biosciences Inc COGT5.97%
Spyre Therapeutics Inc SYRE5.37%
Billiontoone Inc BLLN4.86%
Guardant Health Inc GH4.60%
Replimune Group Inc REPL4.32%
VeraDermics Inc MANE3.61%
TransMedics Group Inc TMDX3.43%

Comparable funds

  • BCLOiShares BBB-B CLO Active ETF
  • DEEDFirst Trust Securitized Plus ETF
  • ICAPInfrastructure Capital Equity Income Fund ETF
  • PPIAstoria Real Assets ETF
  • QARPXtrackers Russell 1000 US Quality at a Reasonable Price ETF
  • RXLProShares - Ultra Health Care
  • SURISimplify Propel Opportunities ETF
  • TBFProShares - Short 20+ Year Treasury

More Emerald ETFs

  • SPITF/m Emerald Special Situations ETF